|
BIBLIOGRAFIA
- IFN - A Dosing
Frequency and HCV Genotype Affect Early Viral Kinetics More Than Addition
of Ribavirin. Medeiros-Filho, J.E.M.; Neumann, A.U.; Pinho, J.R.;
Mello, I.M.V.G.C.; Gatura, S.; Carrilho, F.J. VII International Symposium
on Hepatitis C and Related Viruses. Sydney, Australia; December 2000.
- The Prevalence
of Hepatitis C Virus Infection in the United States, 1998 through
1994. Alter, M.J.; Kruszon-Moran, D.; Nainan, O.V. et al. N. Engl.
J. Med. 1999; 341:556-562.
- Updated Long-Term
Mortality of Transfusion-Associated Hepatitis (TAH) Non-A, Non-B and
C. Wright, E.C.; Seef, L.B.; Hollinger, F.B. et al. Hepatology 1998;
28:272A.
- Hepatitis C
Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon -
A Therapy. Neumann, A.U.; Lam, N.P.; Dahari, H.; Gretch, D.R.; Wiley,
T.E.; Layden, T.J.; Perelson, A.S. Science 1998; 282:103-108.
- Recovery, Persistence
and Sequelae in Hepatitis C Virus Infection. A Perspective on Long-Term
Outcome. Alter, H.J.; Seef, L.B. Sem. Liver Disease, 2000.
- Natural History
of Liver Fibrosis Progression in Patients with Chronic Hepatitis C.
Poynard, T.; Bedossa, P.; Opolon, P. Lancet 1997; 349:825-832.
|